RTI uses cookies to offer you the best experience online. By clicking “accept” on this website, you opt in and you agree to the use of cookies. If you would like to know more about how RTI uses cookies and how to manage them please view our Privacy Policy here. You can “opt out” or change your mind by visiting: http://optout.aboutads.info/. Click “accept” to agree.
What medical examiner’s and coroner’s offices should know about molecular autopsy
Christensen, E. R., Gomez Cardoso, A., McKay, J., Shute, R. L., Grassel, J., & Ropero-MIller, J. D. (2023). What medical examiner’s and coroner’s offices should know about molecular autopsy. Forensic Technology Center of Excellence. https://forensiccoe.org/report-2023-mec-molecular-autopsy/
A molecular autopsy consists of “postmortem genetic testing of decedents who died naturally, suddenly, and unexpectedly at young ages.” Molecular autopsies can enable a more accurate determination of cause of death in cases where the scene investigation, medical records review, toxicological analysis, and autopsy procedures have yielded negative or inconclusive results or positive results that may indicate a genetic cause. Knowing which variants are detected in the decedent can help guide genetic counselor recommendations for future testing, including which relatives may be highest at risk because of the variants’ inheritance patterns, and assist physicians in providing more precise medical care and monitoring recommendations for patients who have a higher predisposition to develop conditions that cause sudden death.